Maravai Lifesciences Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Maravai Lifesciences Holdings, Inc.
7.80
−0.32%
vs ±27.5% implied · ×0.01
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | GtcrGtcr | $125.7M | 14.30% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $62.2M | 7.08% | +6.69% | |
| 3 | BraidwellBraidwell | $54.3M | 6.18% | −15.01% | |
| 4 | 12 West Capital Management12 West | $44.1M | 5.01% | −2.75% | |
| 5 | Millennium ManagementMillennium | $40.6M | 4.62% | +294.56% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $33.0M | 3.75% | −3.05% | |
| 7 | Ophir Asset Management PtyOphir Asset Management Pty | $30.1M | 3.43% | new | |
| 8 | Renaissance TechnologiesRenaissance Technologies | $28.7M | 3.27% | +8.01% | |
| 9 | Deutsche Bank AG\Deutsche Bank AG\ | $26.9M | 3.06% | +401.59% | |
| 10 | First Eagle Investment ManagementFirst Eagle | $22.9M | 2.61% | +45.44% | |
| 11 | Geode Capital ManagementGeodeindex-like | $19.5M | 2.22% | +10.66% | |
| 12 | State StreetState Streetindex-like | $18.1M | 2.06% | +19.47% | |
| 13 | NuveenNuveenindex-like | $17.8M | 2.03% | +1141.63% | |
| 14 | JPMorgan ChaseJPMorgan Chase | $16.6M | 1.88% | +625.96% | |
| 15 | Two Sigma InvestmentsTwo Sigma | $14.1M | 1.60% | +42.79% | |
| 16 | Monaco Asset Management SAMMonaco Asset Management SAM | $13.9M | 1.58% | −34.78% | |
| 17 | Citadel AdvisorsCitadel | $13.7M | 1.55% | +36.07% | |
| 18 | Prudential FinancialPrudential Financial | $13.4M | 1.53% | +11552.16% | |
| 19 | Point72 Asset ManagementPoint72 | $12.5M | 1.42% | −37.43% | |
| 20 | Morgan StanleyMorgan Stanley | $11.9M | 1.35% | −42.51% | |
| 21 | Philosophy Capital ManagementPhilosophy | $11.9M | 1.35% | −27.95% | |
| 22 | Tudor Investment Corp ET ALTudor Investment Corp ET AL | $11.5M | 1.31% | +365.86% | |
| 23 | Royce & AssociatesRoyce & | $11.3M | 1.28% | 0.00% | |
| 24 | General American InvestorsGeneral American Investors | $10.7M | 1.22% | 0.00% | |
| 25 | Hillsdale Investment ManagementHillsdale | $10.5M | 1.19% | new |
178 managers report $879.2M of Maravai Lifesciences on form 13F for the quarter ended Jun 30 '26. 28 of them hold 80% of it; Gtcr is largest at 14.30%.
Expected move
Inputs8Q avg ±11.7%·×1.78·rich
straddle ±23.9%
spot 7.81exp Nov 20ATM strike 7.5ATM straddle 2.20IV 150%